Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial
ConclusionsThe estimates of cost-effectiveness for CO-PCI vs. MV-PCI have been shown to change depending on the time horizon and type of economic evaluation performed. The results favoured a long-term horizon analysis for avoiding underestimation of QALY gains from the CO-PCI arm.
Source: The European Journal of Health Economics - Category: Health Management Source Type: research
More News: Angioplasty | Cardiogenic Shock | Cardiology | Coronary Angioplasty | Diabetes | Economics | Endocrinology | Germany Health | Health Management | Heart | Heart Attack | Percutaneous Coronary Intervention | Renal Failure | UK Health